vs
Side-by-side financial comparison of Community Healthcare Trust Inc (CHCT) and Phathom Pharmaceuticals, Inc. (PHAT). Click either name above to swap in a different company.
Phathom Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($57.6M vs $31.5M, roughly 1.8× Community Healthcare Trust Inc). On growth, Phathom Pharmaceuticals, Inc. posted the faster year-over-year revenue change (94.1% vs 4.8%).
Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...
Phathom Pharmaceuticals is a clinical-stage biopharmaceutical firm focused on developing and commercializing innovative therapies for gastrointestinal diseases. Its lead product candidates address acid-related disorders, inflammatory bowel disease, and other GI conditions, serving patients mainly across North America and Europe.
CHCT vs PHAT — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $31.5M | $57.6M |
| Net Profit | $2.5M | — |
| Gross Margin | — | 86.7% |
| Operating Margin | — | — |
| Net Margin | 8.1% | — |
| Revenue YoY | 4.8% | 94.1% |
| Net Profit YoY | 60.2% | 71.6% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $31.5M | — | ||
| Q4 25 | $30.9M | $57.6M | ||
| Q3 25 | $31.1M | $49.5M | ||
| Q2 25 | $29.1M | $39.5M | ||
| Q1 25 | $30.1M | $28.5M | ||
| Q4 24 | $29.3M | $29.7M | ||
| Q3 24 | $29.6M | $16.4M | ||
| Q2 24 | $27.5M | $7.3M |
| Q1 26 | $2.5M | — | ||
| Q4 25 | $14.4M | — | ||
| Q3 25 | $1.6M | $-30.0M | ||
| Q2 25 | $-12.6M | $-75.8M | ||
| Q1 25 | $1.6M | $-94.3M | ||
| Q4 24 | $1.8M | — | ||
| Q3 24 | $1.7M | $-85.6M | ||
| Q2 24 | $-10.4M | $-91.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 87.5% | ||
| Q2 25 | — | 87.2% | ||
| Q1 25 | — | 86.9% | ||
| Q4 24 | — | 87.1% | ||
| Q3 24 | — | 85.6% | ||
| Q2 24 | — | 81.2% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | -30.8% | ||
| Q2 25 | — | -151.7% | ||
| Q1 25 | — | -276.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -433.0% | ||
| Q2 24 | — | -1055.4% |
| Q1 26 | 8.1% | — | ||
| Q4 25 | 46.6% | — | ||
| Q3 25 | 5.3% | -60.5% | ||
| Q2 25 | -43.2% | -191.9% | ||
| Q1 25 | 5.3% | -330.7% | ||
| Q4 24 | 6.3% | — | ||
| Q3 24 | 5.9% | -523.3% | ||
| Q2 24 | -37.9% | -1248.6% |
| Q1 26 | — | — | ||
| Q4 25 | $0.52 | — | ||
| Q3 25 | $0.03 | $-0.41 | ||
| Q2 25 | $-0.50 | $-1.05 | ||
| Q1 25 | $0.03 | $-1.31 | ||
| Q4 24 | $0.04 | — | ||
| Q3 24 | $0.04 | $-1.32 | ||
| Q2 24 | $-0.42 | $-1.56 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.6M | $130.0M |
| Total DebtLower is stronger | — | $209.1M |
| Stockholders' EquityBook value | $421.3M | $-438.2M |
| Total Assets | $1.0B | $259.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $2.6M | — | ||
| Q4 25 | $3.3M | $130.0M | ||
| Q3 25 | $3.4M | $135.2M | ||
| Q2 25 | $4.9M | $149.6M | ||
| Q1 25 | $2.3M | $212.3M | ||
| Q4 24 | $4.4M | $297.3M | ||
| Q3 24 | $2.8M | $334.7M | ||
| Q2 24 | $734.0K | $276.2M |
| Q1 26 | — | — | ||
| Q4 25 | $532.2M | $209.1M | ||
| Q3 25 | $530.1M | $207.1M | ||
| Q2 25 | $500.1M | $205.1M | ||
| Q1 25 | $496.0M | $203.2M | ||
| Q4 24 | $486.0M | $201.4M | ||
| Q3 24 | $473.7M | $175.7M | ||
| Q2 24 | $457.6M | $174.4M |
| Q1 26 | $421.3M | — | ||
| Q4 25 | $429.4M | $-438.2M | ||
| Q3 25 | $426.8M | $-422.5M | ||
| Q2 25 | $437.8M | $-405.8M | ||
| Q1 25 | $461.3M | $-338.4M | ||
| Q4 24 | $476.0M | $-253.6M | ||
| Q3 24 | $477.2M | $-187.1M | ||
| Q2 24 | $497.8M | $-233.8M |
| Q1 26 | $1.0B | — | ||
| Q4 25 | $990.8M | $259.1M | ||
| Q3 25 | $987.3M | $240.3M | ||
| Q2 25 | $966.3M | $250.2M | ||
| Q1 25 | $985.1M | $294.2M | ||
| Q4 24 | $992.6M | $378.3M | ||
| Q3 24 | $981.8M | $387.0M | ||
| Q2 24 | $983.2M | $319.4M |
| Q1 26 | — | — | ||
| Q4 25 | 1.24× | — | ||
| Q3 25 | 1.24× | — | ||
| Q2 25 | 1.14× | — | ||
| Q1 25 | 1.08× | — | ||
| Q4 24 | 1.02× | — | ||
| Q3 24 | 0.99× | — | ||
| Q2 24 | 0.92× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-166.8M |
| Free Cash FlowOCF − Capex | — | $-167.0M |
| FCF MarginFCF / Revenue | — | -290.0% |
| Capex IntensityCapex / Revenue | — | 0.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-328.9M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $56.4M | $-166.8M | ||
| Q3 25 | $12.7M | $-14.1M | ||
| Q2 25 | $13.8M | $-62.7M | ||
| Q1 25 | $14.4M | $-84.9M | ||
| Q4 24 | $58.9M | $-266.8M | ||
| Q3 24 | $13.8M | $-63.6M | ||
| Q2 24 | $16.7M | $-70.7M |
| Q1 26 | — | — | ||
| Q4 25 | $35.9M | $-167.0M | ||
| Q3 25 | $7.6M | $-14.1M | ||
| Q2 25 | $9.6M | $-62.8M | ||
| Q1 25 | $9.7M | $-84.9M | ||
| Q4 24 | $34.2M | $-266.9M | ||
| Q3 24 | $6.7M | $-63.6M | ||
| Q2 24 | $9.5M | $-70.8M |
| Q1 26 | — | — | ||
| Q4 25 | 116.0% | -290.0% | ||
| Q3 25 | 24.6% | -28.6% | ||
| Q2 25 | 32.9% | -159.0% | ||
| Q1 25 | 32.3% | -297.9% | ||
| Q4 24 | 116.9% | -899.8% | ||
| Q3 24 | 22.5% | -389.0% | ||
| Q2 24 | 34.7% | -966.2% |
| Q1 26 | — | — | ||
| Q4 25 | 66.3% | 0.4% | ||
| Q3 25 | 16.3% | 0.1% | ||
| Q2 25 | 14.5% | 0.2% | ||
| Q1 25 | 15.6% | 0.1% | ||
| Q4 24 | 84.1% | 0.5% | ||
| Q3 24 | 24.2% | 0.3% | ||
| Q2 24 | 26.1% | 0.6% |
| Q1 26 | — | — | ||
| Q4 25 | 3.91× | — | ||
| Q3 25 | 7.76× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 9.06× | — | ||
| Q4 24 | 32.14× | — | ||
| Q3 24 | 7.92× | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
